We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

50 hedge funds and large institutions have $357M invested in Precision BioSciences in 2019 Q1 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.35% more ownership

Funds ownership: 0% → 1.35% (+1.4%)

Holders
50
Holders Change
+50
Holders Change %
–
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
50
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VP
venBio Partners
California
+$75.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$66.1M
3
RCM
RA Capital Management
Massachusetts
+$32.6M
4
Franklin Resources
Franklin Resources
California
+$21.2M
5
CI
Cowen Inc
New York
+$17.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WMSA
26
Weiss Multi-Strategy Advisers
New York
$1.76M +$1.74M +3,272 New
Goldman Sachs
27
Goldman Sachs
New York
$1.72M +$1.7M +3,199 New
DP
28
DSAM Partners
United Kingdom
$1.35M +$1.33M +2,500 New
LM
29
Luminus Management
Texas
$1.35M +$1.33M +2,500 New
Principal Financial Group
30
Principal Financial Group
Iowa
$1.35M +$1.33M +2,500 New
Vanguard Group
31
Vanguard Group
Pennsylvania
$1.35M +$1.33M +2,500 New
HCMT
32
Highland Capital Management (Texas)
Texas
$1.17M +$1.15M +2,167 New
MWNA
33
Marshall Wace North America
New York
$939K +$926K +1,744 New
Citadel Advisors
34
Citadel Advisors
Florida
$867K +$855K +1,610 New
JP Morgan Chase
35
JP Morgan Chase
New York
$718K +$708K +1,333 New
Norges Bank
36
Norges Bank
Norway
$628K +$620K +1,167 New
DIM
37
DC Investments Management
Virginia
$618K +$609K +1,147 New
Victory Capital Management
38
Victory Capital Management
Texas
$427K +$421K +793 New
NIP
39
Nicholas Investment Partners
California
$390K +$384K +724 New
PPA
40
Parametric Portfolio Associates
Washington
$223K +$219K +413 New
ECM
41
ExodusPoint Capital Management
New York
$215K +$212K +400 New
UBS Group
42
UBS Group
Switzerland
$167K +$165K +310 New
SG Americas Securities
43
SG Americas Securities
New York
$144K +$142K +267 New
Legal & General Group
44
Legal & General Group
United Kingdom
$70K +$70.6K +133 New
KC
45
KCL Capital
New York
$18K +$17.5K +33 New
CCA
46
Catalyst Capital Advisors
New York
$6K +$6.37K +12 New
Morgan Stanley
47
Morgan Stanley
New York
$2K +$1.59K +3 New
Citigroup
48
Citigroup
New York
$2K +$2.12K +4 New
FIA
49
FNY Investment Advisers
New York
$2K +$2.65K +5 New
Carson Wealth (CWM LLC)
50
Carson Wealth (CWM LLC)
Nebraska
$1K +$2.12K +4 New
1
2

DTIL Hedge Fund Activity: Q1 2019 in Review

50 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2019, worth a combined $357M.

Buyers outnumbered sellers: 50 funds opened new DTIL positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was venBio Partners, opening a new position worth an estimated $75.5M.

  • 50 institutional investors held Precision BioSciences (DTIL) as of Q1 2019, up from 0 in Q4 2018.
  • Funds reported $357M of Precision BioSciences stock for Q1 2019.
  • 50 funds opened new Precision BioSciences positions in Q1 2019 and 0 closed out, a net change of +50 holders.
  • The largest Precision BioSciences buyer in Q1 2019 was venBio Partners, an estimated $75.5M added.

Based on aggregated 13F filings for Q1 2019.